Literature DB >> 10887948

Purinoceptor-mediated calcium mobilization and cellular proliferation in cultured bovine corneal endothelial cells.

S H Cha1, T W Hahn, T Sekine, K H Lee, H Endou.   

Abstract

In the present study, we investigated the effect of adenosine triphosphate (ATP) on cytosolic free calcium mobilization and mitogenic activity in cultured bovine corneal endothelial cells (BCEC). The [Ca2+]i was determined using a Ca2+ sensitive indicator, Fura-2/AM, and cell proliferation was evaluated by counting the cell number. ATP, its metabolites and analogs caused transient increase in [Ca2+]i in a concentration-dependent manner (10(-7) M-10(-3) M) and the potency of agonists was ordered as follows: 2-methylthio-ATP > uridine triphosphate > ATP > adenosine diphosphate. Adenosine monophosphate and adenosine did not affect [Ca2+]i. ATP (10(-4) M) also promoted the accumulation of inositol trisphosphate (IP3). The ATP-induced transient [Ca2+]i increase and IP3 accumulation were attenuated by pretreatment with a phospholipase C inhibitor, U-73122 (5 microM), for 30 min. ATP (10(-5) M) significantly enhanced the proliferation of BCEC. ATP-induced [Ca2+]i increase and cell proliferation were inhibited by a purinoceptor antagonist, suramin (10(-4) M). Thus, the present study indicates that BCEC contain P2 purinoceptors that regulate their proliferation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10887948     DOI: 10.1254/jjp.82.181

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  9 in total

1.  Expression and functional evaluation of transient receptor potential channel 4 in bovine corneal endothelial cells.

Authors:  Qiang Xie; Yan Zhang; Xing Cai Sun; Changbin Zhai; Joseph A Bonanno
Journal:  Exp Eye Res       Date:  2005-07       Impact factor: 3.467

Review 2.  Novel roles of perivascular nerves on neovascularization.

Authors:  Lei Hao; Zhongmin Zou; Hong Tian; Yubo Zhang; Chuan Song; Huchuan Zhou; Lei Liu
Journal:  Neurol Sci       Date:  2014-11-29       Impact factor: 3.307

3.  P2Y1 and P2Y13 purinergic receptors mediate Ca2+ signaling and proliferative responses in pulmonary artery vasa vasorum endothelial cells.

Authors:  Taras Lyubchenko; Heather Woodward; Kristopher D Veo; Nana Burns; Hala Nijmeh; Ganna A Liubchenko; Kurt R Stenmark; Evgenia V Gerasimovskaya
Journal:  Am J Physiol Cell Physiol       Date:  2010-10-20       Impact factor: 4.249

4.  Functional Expression of P2Y Receptors in WERI-Rb1 Retinoblastoma Cells.

Authors:  Na-Hyun Kim; Kyu-Sang Park; Joon Hyung Sohn; Byung-Il Yeh; Chang Mann Ko; In Deok Kong
Journal:  Korean J Physiol Pharmacol       Date:  2011-02-28       Impact factor: 2.016

5.  Adenosine-5'-triphosphate up-regulates proliferation of human cardiac fibroblasts.

Authors:  Jing-Bo Chen; Wen-Juan Liu; Hui Che; Jie Liu; Hai-Ying Sun; Gui-Rong Li
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

6.  Thymidine 5'-O-monophosphorothioate induces HeLa cell migration by activation of the P2Y6 receptor.

Authors:  Edyta Gendaszewska-Darmach; Marcin Szustak
Journal:  Purinergic Signal       Date:  2016-01-08       Impact factor: 3.765

7.  Nucleotide receptors as targets in the pharmacological enhancement of dermal wound healing.

Authors:  Edyta Gendaszewska-Darmach; Marta Kucharska
Journal:  Purinergic Signal       Date:  2011-04-26       Impact factor: 3.765

8.  Extracellular ATP is a pro-angiogenic factor for pulmonary artery vasa vasorum endothelial cells.

Authors:  Evgenia V Gerasimovskaya; Heather N Woodward; Doug A Tucker; Kurt R Stenmark
Journal:  Angiogenesis       Date:  2007-12-11       Impact factor: 9.596

Review 9.  P2Y Purinergic Receptors, Endothelial Dysfunction, and Cardiovascular Diseases.

Authors:  Derek Strassheim; Alexander Verin; Robert Batori; Hala Nijmeh; Nana Burns; Anita Kovacs-Kasa; Nagavedi S Umapathy; Janavi Kotamarthi; Yash S Gokhale; Vijaya Karoor; Kurt R Stenmark; Evgenia Gerasimovskaya
Journal:  Int J Mol Sci       Date:  2020-09-18       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.